legislation: 103-hr-4151

Congressional bills and resolutions from Congress.gov, filtered to policy areas relevant to environmental, health, agriculture, and wildlife regulation.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

bill_id congress bill_type bill_number title policy_area introduced_date latest_action_date latest_action_text origin_chamber sponsor_name sponsor_state sponsor_party sponsor_bioguide_id cosponsor_count summary_text update_date url
103-hr-4151 103 hr 4151 Essential Pharmaceuticals Act of 1994 Commerce 1994-03-24 1994-03-31 Referred to the Subcommittee on Intellectual Property and Judicial Administration. House Rep. Nadler, Jerrold [D-NY-8] NY D N000002 0 Essential Pharmaceuticals Act of 1994 - Directs the Secretary of Health and Human Services to notify the Commissioner of Patents and Trademarks if the Secretary determines that the owner of a patent which claims a product or a method of using or manufacturing a product and which may be extended has not taken all reasonable steps toward the commercial marketing or use of that product whose availability to the public is of vital importance to the public health or welfare. Requires the Commissioner to provide for the compulsory licensing of all patents relating to that product. Allows an individual aggrieved by a decision of: (1) the Commissioner under this Act to appeal that decision to the Board of Patent Appeals and Interferences, after paying the fee for such appeal; and (2) the Board to appeal that decision to the United States Court of Appeals for the Federal Circuit. 2025-08-26T13:50:51Z  

Links from other tables